Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSL412 in Adults and Older Adults
NCT00479648Phase 2Completed
- Sponsor
- CSL Seqirus
- Start
- May 2007
- Primary completion
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CSL412 in influenza, sponsored by CSL Seqirus. Started May 2007; status: completed.
02
Drugs
CSL412
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00479648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479648.